Apply for active substance renewal by the deadline to keep products on the GB market.
Under the GB Biocidal Products Regulation (GB BPR), active substance approvals will expire unless a renewal application is submitted at least 550 days before their expiry date.
The 550-day deadline is coming up for the following active substance/product type combination under GB BPR:
27 August 2025
- Bacillus thuringiensis subsp. kurstaki, strain ABTS-351 (CAS N/A EC N/A) in product type 18
Any person, company or task force/consortium can support an active substance/product type combination for renewal – it doesn’t have to be the original supporter.
Check the GB Article 95 List to see who the original supporters were.
If this active substance/product type combination is important to you, consider contacting your supplier to let them know.
If a renewal application is not submitted for the above active substance/product type combination under GB BPR, the approval will expire. This means the active substance will no longer be able to be used in biocidal products of the relevant product type in GB.
In addition articles treated with such products will no longer be able to be placed on the market in GB.
Biocidal products must be phased off the GB market.
The active substance/product type combinations listed are due to expire under the GB BPR on the following date:
31 August 2025
- Iodine (CAS 7553-56-2 EC 231-442-4) in product types 1, 4 and 22
- n-Decanoic acid (decanoic acid) (CAS 334-48-5 EC 206-376-4) in product types 18 and 19
- n-Octanoic acid (octanoic acid) (CAS 124-07-2 EC 204-677-5) in product type 18
- Polyvinylpyrrolidone iodine (CAS 25655-41-8 EC 607-771-8) in product types 1, 4 and 22
Once the approvals expire, the active substances will no longer be able to be used in biocidal products of the relevant product types in GB.
In addition articles treated with such products will no longer be able to be placed on the market in GB.
If you hold an affected GB BPR product authorisation or Control of Pesticides Regulations (COPR) product approval, we will contact you about cancelling or revoking your authorisation or approval. You will have an opportunity to submit comments or additional information and we will take account of these when finalising our decision.
If you are aware of any disproportionate negative impacts that are likely to arise from the expiry of the active substance/product type combinations listed, please contact us.
|
